Triple
T6929627
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Royal Institute for Experimental Therapy, Frankfurt |
E160399
|
entity |
| Predicate | hasAlternativeName |
P39
|
FINISHED |
| Object | Königliches Institut für experimentelle Therapie |
E160399
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Königliches Institut für experimentelle Therapie | Statement: [Royal Institute for Experimental Therapy, Frankfurt, hasAlternativeName, Königliches Institut für experimentelle Therapie]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Königliches Institut für experimentelle Therapie Context triple: [Royal Institute for Experimental Therapy, Frankfurt, hasAlternativeName, Königliches Institut für experimentelle Therapie]
-
A.
Institute of Cancer Research
The Institute of Cancer Research is a specialized branch of Canada’s federal health research funding agency that focuses on supporting and coordinating cancer-related research initiatives.
-
B.
Royal Institute for Experimental Therapy, Frankfurt
chosen
The Royal Institute for Experimental Therapy in Frankfurt was a pioneering biomedical research institute in Germany, closely associated with Paul Ehrlich’s groundbreaking work in immunology and chemotherapy.
-
C.
UCL Cancer Institute
UCL Cancer Institute is a leading cancer research center in London focused on understanding cancer biology and developing innovative treatments and diagnostics.
-
D.
Cambridge Clinical Research Centre
Cambridge Clinical Research Centre is a major medical research facility based at the Cambridge Biomedical Campus, supporting advanced clinical studies and translational medicine.
-
E.
Princess Margaret Cancer Centre
Princess Margaret Cancer Centre is a leading Canadian cancer research and treatment hospital affiliated with the University Health Network in Toronto.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69c6884e15208190b9e91487eaafcf85 |
completed | March 27, 2026, 1:38 p.m. |
| NER | Named-entity recognition | batch_69c6da1f5fcc8190b43f53f90fc1821c |
completed | March 27, 2026, 7:27 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69c7514774d88190af212d7953014703 |
completed | March 28, 2026, 3:55 a.m. |
Created at: March 27, 2026, 2:27 p.m.